National Institutes of Health
continues—Federal programs
Today
The largest public funder of biomedical research.
Under the plan
Continues unchanged in the ledger. Optional increase to offset lower pharmaceutical R&D incentives (not costed).
Trade-off
Holding NIH flat isolates the coverage change; raising it would partly offset lost private R&D at a public cost.
Money
- Non-commercial research$70.4B → $70.4B